{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T11:04:03Z","timestamp":1781867043638,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,11,7]],"date-time":"2006-11-07T00:00:00Z","timestamp":1162857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2006,11,17]]},"DOI":"10.1007\/s00228-006-0205-0","type":"journal-article","created":{"date-parts":[[2006,11,6]],"date-time":"2006-11-06T10:22:07Z","timestamp":1162808527000},"page":"1041-1048","source":"Crossref","is-referenced-by-count":29,"title":["Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls"],"prefix":"10.1007","volume":"62","author":[{"given":"Maria Skaalum","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3nrit","family":"Halling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Damkier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Grandjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Weihe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Br\u00f8sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,7]]},"reference":[{"key":"205_CR1","first-page":"414","volume":"270","author":"T Shimada","year":"1994","unstructured":"Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414\u2013423","journal-title":"J Pharmacol Exp Ther"},{"key":"205_CR2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1258\/0007142991902439","volume":"55","author":"CR Wolf","year":"1999","unstructured":"Wolf CR, Smith G (1999) Pharmacogenetics. Br Med Bull 55:366\u2013386","journal-title":"Br Med Bull"},{"key":"205_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003088-199500291-00005","volume":"29","author":"K Br\u00f8sen","year":"1995","unstructured":"Br\u00f8sen K (1995) Drug interactions and the cytochrome P450 system. Clin Pharmacokinet 29:20\u201325","journal-title":"Clin Pharmacokinet"},{"key":"205_CR4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/carcin\/23.7.1199","volume":"23","author":"T Shimada","year":"2002","unstructured":"Shimada T, Inoue K, Suzuki Y, Kawai T et al (2002) Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL\/6J mice. Carcinogenesis 23:1199\u20131207","journal-title":"Carcinogenesis"},{"issue":"12","key":"205_CR5","first-page":"3218","volume":"49","author":"T Shimada","year":"1989","unstructured":"Shimada T, Iwasaki M, Martin MV, Guengerich FP (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535\/pSK1002. Cancer Res 49(12):3218\u20133228","journal-title":"Cancer Res"},{"issue":"5","key":"205_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00008571-199510000-00001","volume":"5","author":"DL Eaton","year":"1995","unstructured":"Eaton DL, Gallagher EP, Bammler TK, Kunze KL (1995) Role of cytochrome CYP1A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5(5):259\u2013274, Review","journal-title":"Pharmacogenetics"},{"key":"205_CR7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00544361","volume":"28","author":"DR Abernethy","year":"1985","unstructured":"Abernethy DR, Todd EL (1985) Impairment of caffeine clearence by chromic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 28:425\u2013428","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"205_CR8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00548769","volume":"26","author":"EC Rietveld","year":"1984","unstructured":"Rietveld EC, Broekman MM, Houben JJ, Eskes TK, van Rossum JM (1984) Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids. Eur J Clin Pharmacol 26(3):371\u2013373","journal-title":"Eur J Clin Pharmacol"},{"key":"205_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/clpt.1991.8","volume":"49","author":"W Kalow","year":"1991","unstructured":"Kalow W, Tang B-K (1991) Caffeine as a metabolic probe: exploration of enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther 49:44\u201348","journal-title":"Clin Pharmacol Ther"},{"key":"205_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002280050394","volume":"53","author":"D Schrenk","year":"1998","unstructured":"Schrenk D, Brockmeier D, Morike K, Bock KW, Eichelbaum M (1998) A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur J Clin Pharmacol 53:361\u2013367","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"205_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cpt197824140","volume":"24","author":"WD Parsons","year":"1978","unstructured":"Parsons WD, Neims AH (1978) Effect of smoking on caffeine clearance. Clin Pharmacol Ther 24(1):40\u201345","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"205_CR12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00008571-199206000-00003","volume":"2","author":"MA Butler","year":"1992","unstructured":"Butler MA, Lang NP, Young JF, Caporaso NE et al (1992) Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2(3):116\u2013127","journal-title":"Pharmacogenetics"},{"key":"205_CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00008571-200208000-00008","volume":"12","author":"BB Rasmussen","year":"2002","unstructured":"Rasmussen BB, Brix TH, Kyvik KO, Br\u00f8sen K (2002) The interindividuel differences in the 3-demethylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharamacogenetics 12:473\u2013478","journal-title":"Pharamacogenetics"},{"key":"205_CR14","first-page":"413","volume":"3","author":"M Nakajima","year":"1994","unstructured":"Nakajima M, Yokoi T, Mizutani M, Shin S, Kadlubar FF, Kamataki T (1994) Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol Biomarkers Prev 3:413\u2013421","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"205_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1124\/mol.64.3.659","volume":"64","author":"E Aklillu","year":"2003","unstructured":"Aklillu E, Carrillo JA, Makonnen E, Hellman K et al (2003) Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol Pharmacol 64(3):659\u2013669","journal-title":"Mol Pharmacol"},{"issue":"1","key":"205_CR16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1365-2125.2003.01733.x","volume":"55","author":"C Sachse","year":"2003","unstructured":"Sachse C, Bhambra U, Smith G, Lightfoot TJ et al (2003) Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 55(1):68\u201376","journal-title":"Br J Clin Pharmacol"},{"key":"205_CR17","first-page":"98","volume":"27","author":"J Huang","year":"1999","unstructured":"Huang J, Guo W, Lai M, Guo Y, Lambert GH (1999) Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese. Am Soc Pharmacol Exp Ther 27:98\u2013101","journal-title":"Am Soc Pharmacol Exp Ther"},{"key":"205_CR18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a022352","volume":"125","author":"M Nakajima","year":"1999","unstructured":"Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T (1999) Genetic polymorphism in the 59-flanking region of human CYP1A2 inducibility in humans. J Biochem (Tokyo) 125:803\u2013808","journal-title":"J Biochem (Tokyo)"},{"key":"205_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","volume":"47","author":"C Sachse","year":"1999","unstructured":"Sachse C, Brockmoller J, Bauer S, Roots I (1999) Functional significance of a C\u2192A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47:445\u2013449","journal-title":"Br J Clin Pharmacol"},{"key":"205_CR20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrgentox.2005.08.008","volume":"587","author":"S Pavanello","year":"2005","unstructured":"Pavanello S, Puliero A, Lupi S, Gregorio P, Clonfero E (2005) Influence of the genetic polymorphism in the 5\u2032-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers. Mutat Res 587:59\u201366","journal-title":"Mutat Res"},{"key":"205_CR21","unstructured":"http:\/\/www.imm.ki.se\/CYPalleles\/CYP1A2.htm"},{"key":"205_CR22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10408449409049308","volume":"24","author":"SH Safe","year":"1994","unstructured":"Safe SH (1994) Polychlorinated Biphenyls (PCB): environmental impact, biochemical and toxic responses, and implication for risk assessment. Crit Rev Toxicol 24:87\u2013149","journal-title":"Crit Rev Toxicol"},{"key":"205_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/00498259609046709","volume":"26","author":"BG Lake","year":"1996","unstructured":"Lake BG, Charzat C, Tredger JM, Renwich AB, Beamand JA, Prince RJ (1996) Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and human liver slices. Xenobiotica 26:297\u2013306","journal-title":"Xenobiotica"},{"key":"205_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1289\/ehp.113-a33","volume":"113","author":"EF Fitzgerald","year":"2005","unstructured":"Fitzgerald EF, Hwang S, Lambert G, Gomez M, Tarbell A (2005) PCB exposure and in vivo CYP1A2 activity among native Americans. Environ Health Perspect 113:1\u20136","journal-title":"Environ Health Perspect"},{"key":"205_CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/oem.52.2.86","volume":"52","author":"W Halperin","year":"1995","unstructured":"Halperin W, Kalow W, Sweeney MH, Tang BK et al (1995) Induction of P-450 in workers exposed to dioxin. Occup Environ Med 52:86\u201391","journal-title":"Occup Environ Med"},{"issue":"2","key":"205_CR26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1067\/mcp.2002.126408","volume":"72","author":"K Abraham","year":"2002","unstructured":"Abraham K, Geusau A, Tosun Y, Helge H, Bauer S, Brockmoller J (2002) Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome CYP1A2 induction. Clin Pharmacol Ther 72(2): 163\u2013174","journal-title":"Clin Pharmacol Ther"},{"key":"205_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1289\/ehp.9089175","volume":"89","author":"GH Lambert","year":"1990","unstructured":"Lambert GH, Schoeller DA, Humphrey HE, Kotake AN et al (1990) The caffeine breath test and caffeine urinary metabolite ratios in the Michigan cohort exposed to polybrominated biphenyls: a preliminary study. Environ Health Perspect 89:175\u2013181","journal-title":"Environ Health Perspect"},{"key":"205_CR28","unstructured":"http:\/\/www.atsdr.cdc.gov\/toxprofiles\/tp17.html"},{"key":"205_CR29","first-page":"36","volume":"2","author":"D Bloch","year":"1990","unstructured":"Bloch D, Desportes G, Hoydal K, Jean P (1990) Pilot whaling in the Faroe Islands, July 1986\u2013July 1988. North Atlantic Studies 2:36\u201344","journal-title":"North Atlantic Studies"},{"issue":"4","key":"205_CR30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0892-0362(01)00155-6","volume":"23","author":"P Grandjean","year":"2001","unstructured":"Grandjean P, Weihe P, Burse VW, Needham LL et al (2001) Neurobehavioral deficits associated with PCB in 7-year-old children prenatally exposed to seafood neurotoxicants. Neurotoxicol Teratol 23(4):305\u2013317","journal-title":"Neurotoxicol Teratol"},{"key":"205_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1289\/ehp.5463","volume":"111","author":"MP Longnecker","year":"2003","unstructured":"Longnecker MP, Wolff MS, Gladen BC, Brock JW, Grandjean P et al (2003) Comparison of polychlorinated biphenyl (PCB) levels across studies of human neurodevelopment. Environ Health Perspect 111:65\u201370","journal-title":"Environ Health Perspect"},{"key":"205_CR32","unstructured":"Deutch B, Hansen JC (eds) (2003) AMAP Greenland and the Faroe Islands 1997\u20132001. Danish Environmental Protection Agency, Copenhagen"},{"key":"205_CR33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1067\/mpd.2000.102774","volume":"136","author":"U Steuerwald","year":"2000","unstructured":"Steuerwald U, Weihe P, J\u00f8rgensen PJ, Bjerve K, Brock J et al (2000) Maternal seafood diet, methylmercury exposure, and neonatal neurological function. J Pediatr 136:599\u2013605","journal-title":"J Pediatr"},{"key":"205_CR34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajim.10043","volume":"41","author":"KB Moysich","year":"2002","unstructured":"Moysich KB, Ambrosone CB, Mendola P, Kostyniak PJ et al (2002) Exposures associated with serum organochlorine levels among postmenopausal women from Western New York state. Am J Ind Med 41:102\u2013110","journal-title":"Am J Ind Med"},{"key":"205_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/clpt.1987.126","volume":"42","author":"ME Campbell","year":"1987","unstructured":"Campbell ME, Spielberg SP, Kalow W (1987) A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 42:157\u2013165","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"205_CR36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00228-005-0938-1","volume":"61","author":"J Halling","year":"2005","unstructured":"Halling J, Petersen MS, Damkier P, Nielsen F, Grandjean P et al (2005) Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. Eur J Clin Pharmacol 61(7):491\u2013497","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"205_CR37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0009-9236(97)90114-4","volume":"62","author":"RF Frye","year":"1997","unstructured":"Frye RF, Matzke GR, Adedoyin A, Porter JA, Branch RA (1997) Validation of the five-drug \u201cPittsburgh cocktail\u201d approach for assessment of selective regulation of drug-metabolizing enzymes. Clin Pharmacol Ther 62(4):365\u2013376","journal-title":"Clin Pharmacol Ther"},{"key":"205_CR38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00007691-199606000-00006","volume":"18","author":"BB Rasmussen","year":"1996","unstructured":"Rasmussen BB, Br\u00f8sen K (1996) Determination of urinary metabolites of caffeine for the assessment of cytochrome CYP1A2, xanthine oxidase, and N-acetyltransferase activity in humans. Ther Drug Monit 18:254\u2013262","journal-title":"Ther Drug Monit"},{"key":"205_CR39","doi-asserted-by":"crossref","unstructured":"Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-J\u00f8rgensen E (2006) Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Medicine 3(8): e311. DOI 10.1371\/journal.pmed.0030311","DOI":"10.1371\/journal.pmed.0030311"},{"key":"205_CR40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/enrs.1995.1064","volume":"71","author":"P Grandjean","year":"1995","unstructured":"Grandjean P, Weihe P, Needham LL, Burse VW et al (1995) Effect of a seafood diet on mercury, selenium, arsenic, and PCBs and other organochlorines in human milk. Environ Res 71:29\u201338","journal-title":"Environ Res"},{"key":"205_CR41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0045-6535(94)90324-7","volume":"28","author":"UG Ahlborg","year":"1994","unstructured":"Ahlborg UG, Becking GC, Birnbaum LS, Brouwer A et al (1994) Toxic equivalency factors for dioxin-like PCBs. Chemosphere 28:1049\u20131067","journal-title":"Chemosphere"},{"issue":"5","key":"205_CR42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/clpt.1993.63","volume":"53","author":"W Kalow","year":"1993","unstructured":"Kalow W, Tang BK (1993) The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther 53(5):503\u2013514, Review","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"205_CR43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2125.1995.tb04411.x","volume":"39","author":"LJ Notarianni","year":"1995","unstructured":"Notarianni LJ, Oliver SE, Dobrocky P, Bennett PN, Silverman BW (1995) Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity. Br J Clin Pharmacol 39(1):65\u201369","journal-title":"Br J Clin Pharmacol"},{"key":"205_CR44","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.286.18.2270","volume":"286","author":"KA Phillips","year":"2001","unstructured":"Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W (2001) Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 286:2270\u20132279, Nov","journal-title":"JAMA"},{"key":"205_CR45","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1349-7006.2006.00241.x","volume":"97","author":"SY Bae","year":"2006","unstructured":"Bae SY, Choi SK, Kim KR, Park CS et al (2006) Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci 97:774\u2013779","journal-title":"Cancer Sci"},{"key":"205_CR46","first-page":"4","volume":"521","author":"National Toxicology Program","year":"2006","unstructured":"National Toxicology Program (2006) NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl Toxicol Program Tech Rep Ser 521:4\u2013232","journal-title":"Natl Toxicol Program Tech Rep Ser"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-006-0205-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-006-0205-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-006-0205-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:51:34Z","timestamp":1558702294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-006-0205-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,7]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,11,17]]}},"alternative-id":["205"],"URL":"https:\/\/doi.org\/10.1007\/s00228-006-0205-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,7]]}}}